The common inhalation anesthetic isoflurane induces apoptosis and increases amyloid β protein levels

Anesthesiology

Volumn 104, Issue 5, 2006, Pages 988-994

  Xie, Zhongcong ^a,b   Dong, Yuanlin ^a   Maeda, Uta ^a   Alfille, Paul ^a   Culley, Deborah J ^b,c   Crosby, Gregory ^b,c   Tanzi, Rudolph E ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; CARBON DIOXIDE; CASPASE 3; ISOFLURANE; NITROGEN; OXYGEN;

ALZHEIMER DISEASE; APOPTOSIS; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL VIABILITY; COGNITION; CONTROLLED STUDY; DRUG CYTOTOXICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GLIOMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; INHALATION ANESTHESIA; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN PROCESSING; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; WESTERN BLOTTING; WILD TYPE;

AMYLOID BETA-PROTEIN; AMYLOID BETA-PROTEIN PRECURSOR; ANESTHETICS, INHALATION; APOPTOSIS; BLOTTING, WESTERN; BRAIN NEOPLASMS; CASPASES; CELL LINE, TUMOR; CELL SURVIVAL; DRUG SYNERGISM; ENZYME ACTIVATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; GAMMA-AMINOBUTYRIC ACID; GLIOMA; HUMANS; ISOFLURANE; NERVE TISSUE PROTEINS; TRIGLYCERIDES;

EID: 33646787077     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/00000542-200605000-00015     Document Type: Article

References (34)

1. Glenner GG, Wong CW: Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 1984; 120:885-90
2. Tanzi RE, Bertram L: Twenty years of the Alzheimer's disease amyloid hypothesis: A genetic perspective. Cell 2005; 120:545-55
3. Masliah E, Mallory M, Alford M, Tanaka S, Hansen LA: Caspase dependent DNA fragmentation might be associated with excitotoxicity in Alzheimer disease. J Neuropathol Exp Neurol 1998; 57:1041-52
4. Yang F, Sun X, Beech W, Teter B, Wu S, Sigel J, Vinters HV, Frautschy SA, Cole GM: Antibody to caspase-cleaved actin detects apoptosis in differentiated neuroblastoma and plaque-associated neurons and microglia in Alzheimer's disease. Am J Pathol 1998; 152:379-89
5. Gervais FG, Xu D, Robertson GS, Vaillancourt JP, Zhu Y, Huang J, LeBlanc A, Smith D, Rigby M, Shearman MS, Clarke EE, Zheng H, Van Der Ploeg LH, Ruffolo SC, Thornberry NA, Xanthoudakis S, Zamboni RJ, Roy S, Nicholson DW: Involvement of caspases in proteolytic cleavage of Alzheimer's amyloid-beta precursor protein and amyloidogenic A beta peptide formation. Cell 1999; 97:395-406
6. Shimohama S, Tanino H, Fujimoto S: Changes in caspase expression in Alzheimer's disease: Comparison with development and aging. Biochem Biophys Res Commun 1999; 256:381-4
7. Raina AK, Hochman A, Ickes H, Zhu X, Ogawa O, Cash AD, Shimohama S, Perry G, Smith MA: Apoptotic promoters and inhibitors in Alzheimer's disease: Who wins out? Prog Neuropsychopharmacol Biol Psychiatry 2003; 27:251-4
8. Kokmen E, Whisnant JP, O'Fallon WM, Chu CP, Beard CM: Dementia after ischemic stroke: A population-based study in Rochester, Minnesota (1960-1984). Neurology 1996; 46:154-9
9. Nagy Z, Esiri MM, Jobst KA, Morris JH, King EM, McDonald B, Joachim C, Litchfield S, Barnetson L, Smith AD: The effects of additional pathology on the cognitive deficit in Alzheimer disease. J Neuropathol Exp Neurol 1997; 56:165-70
10. Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR: Brain infarction and the clinical expression of Alzheimer disease: The Nun Study. JAMA 1997; 277:813-7
11. Jendroska K, Hoffmann OM, Patt S: Amyloid beta peptide and precursor protein (APP) in mild and severe brain ischemia. Ann N Y Acad Sci 1997; 826:401-5
12. Kalaria RN: The role of cerebral ischemia in Alzheimer's disease. Neurobiol Aging 2000; 21:321-30
13. Xie Z, Moir R, Romano DM, Tesco G, Kovacs D, Tanzi RE: Hypocapnia induces caspase-3 activation and increases A-beta production. Neurodegenerative Dis 2004; 1:29-37
14. Eckenhoff RG, Johansson JS, Wei H, Carnini A, Kang B, Wei W, Pidikiti R, Keller JM, Eckenhoff MF: Inhaled anesthetic enhancement of amyloid-beta oligomerization and cytotoxicity. ANESTHESIOLOGY 2004; 101:703-9
15. Xie Z, Romano DM, Tanzi RE: Effects of RNAi-mediated silencing of PEN-2, APH-1a, and nicastrin on wild-type versus FAD mutant forms of presenilin 1. J Mol Neurosci 2005; 25:67-77
16. Xie Z, Romano DM, Tanzi RE: RNA interference-mediated silencing of X11alpha and X11beta attenuates amyloid beta-protein levels via differential effects on beta-amyloid precursor protein processing. J Biol Chem 2005; 280:15413-21
17. Thornberry NA: Caspases: Key mediators of apoptosis. Chem Biol 1998; 5:R97-103
18. Zaugg M, Jamali NZ, Lucchinetti E, Shafiq SA, Siddiqui MA: Norepinephrine-induced apoptosis is inhibited in adult rat ventricular myocytes exposed to volatile anesthetics. ANESTHESIOLOGY 2000; 93:209-18
19. Tyther R, Fanning N, Halligan M, Wang J, Redmond HP, Shorten G: The effect of the anaesthetic agent isoflurane on the rate of neutrophil apoptosis in vitro. Ir J Med Sci 2001; 170:41-4
20. Wise-Faberowski L, Raizada MK, Sumners C: Oxygen and glucose deprivation-induced neuronal apoptosis is attenuated by halothane and isoflurane. Anesth Analg 2001; 93:1281-7
21. Wise-Faberowski L, Aono M, Pearlstein RD, Warner DS: Apoptosis is not enhanced in primary mixed neuronal/glial cultures protected by isoflurane against N-methyl-D-aspartate excitotoxicity. Anesth Analg 2004; 99:1708-14
22. de Klaver MJ, Manning L, Palmer LA, Rich GF: Isoflurane pretreatment inhibits cytokine-induced cell death in cultured rat smooth muscle cells and human endothelial cells. ANESTHESIOLOGY 2002; 97:24-32
23. Kawaguchi M, Drummond JC, Cole DJ, Kelly PJ, Spurlock MP, Patel PM: Effect of isoflurane on neuronal apoptosis in rats subjected to focal cerebral ischemia. Anesth Analg 2004; 98:798-805
24. 2+ and mitogen-activated protein kinases. ANESTHESIOLOGY 2005; 102:606-15
25. Kvolik S, Glavas-Obrovac L, Bares V, Karner I: Effects of inhalation anesthetics halothane, sevoflurane, and isoflurane on human cell lines. Life Sci 2005; 77:2369-83
26. Loop T, Dovi-Akue D, Frick M, Roesslein M, Egger L, Humar M, Hoetzel A, Schmidt R, Borner C, Pahl HL, Geiger KK, Pannen BH: Volatile anesthetics induce caspase-dependent, mitochondria-mediated apoptosis in human T lymphocytes in vitro. ANESTHESIOLOGY 2005; 102:1147-57
27. Wei H, Kang B, Wei W, Liang G, Meng QC, Li Y, Eckenhoff RG: Isoflurane and sevoflurane affect cell survival and BCL-2/BAX ratio differently. Brain Res 2005; 1037:139-47
28. Matsuoka H, Kurosawa S, Horinouchi T, Kato M, Hashimoto Y: Inhalation anesthetics induce apoptosis in normal peripheral lymphocytes in vitro. ANESTHESIOLOGY 2001; 95:1467-72
29. Lu DC, Rabizadeh S, Chandra S, Shayya RF, Ellerby LM, Ye X, Salvesen GS, Koo EH, Bredesen DE: A second cytotoxic proteolytic peptide derived from amyloid beta-protein precursor. Nat Med 2000; 6:397-404
30. Galvan V, Chen S, Lu D, Logvinova A, Goldsmith P, Koo EH, Bredesen DE: Caspase cleavage of members of the amyloid precursor family of proteins. J Neurochem 2002; 82:283-94
31. Kovacs DM, Mancini R, Henderson J, Na SJ, Schmidt SD, Kim TW, Tanzi RE: Staurosporine-induced activation of caspase-3 is potentiated by presenilin 1 familial Alzheimer's disease mutations in human neuroglioma cells. J Neurochem 1999; 73:2278-85
32. Holtzman DM, Deshmukh M: Caspases: A treatment target for neurodegenerative disease? Nat Med 1997; 3:954-5
33. Lunkes A, Trottier Y, Mandel JL: Pathological mechanisms in Huntington's disease and other polyglutamine expansion diseases. Essays Biochem 1998; 33:149-63
34. Namura S, Zhu J, Fink K, Endres M, Srinivasan A, Tomaselli KJ, Yuan J, Moskowitz MA: Activation and cleavage of caspase-3 in apoptosis induced by experimental cerebral ischemia. J Neurosci 1998; 18:3659-68